Can Merck's New Products Aid Growth as Keytruda LOE Test Looms?
unknown
📅 Published: 2025-12-04 16:20
📰 Source: Yahoo
📝 Words: 19
📝 Article Content
MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.
📄 Summary
MRK banks on Capvaxive, Winrevair and other new launches to counter Keytruda's looming 2028 LOE and record long-term growth.
Scraping Metadata:
Scraped At:
Unknown
Created At:
2025-12-11 18:38:38
Updated At:
2025-12-11 18:38:38
Scraping Job ID:
N/A
Stock Mentions:
MRK - Merck & Co. Inc.
Relevance: N/A